Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 233
Ph III recruiting: 18
Growth YoY: +3.1%
Industry share: 29%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.2%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00816686	A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer	terminated	Phase 1	7	Astellas Pharma IncINDUSTRY	1	Feb 27, 2013	clinicaltrials
NCT00492440	Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer	terminated	Phase 1	9	Cytheris SAINDUSTRY	1	Oct 18, 2012	clinicaltrials